Members of the American Society of Human Genetics (ASHG) strive to further understanding of the human genome for the betterment of science, health and society. As a community of genetics researchers, ASHG is deeply concerned by the passage and implementation of Texas law S.B. 8 and the potential passage of similar bills nationwide, which will... Read More
Nascent Transcript Author: Nicole Ferraro Direct-to-consumer (DTC) genetic testing has allowed millions to directly interact with their genetic data and test results. This presents largely uncharted avenues in which our work as geneticists interacts with the public. A recent example involved a genome-wide association study1 that produced a polygenic risk score explaining <1% of variance... Read More
Tests for Genetic Diseases There are many different tests available for genetic diseases. Some people use direct-to-consumer testing to see whether they are at risk for certain genetic diseases. Genetic testing is also available through a genetic specialist or your primary care physician. In the medical setting, your doctor will first determine if you would... Read More
In 2018, the U.S. Food and Drug Administration (FDA) invited comments on its intention to exempt a list of class II devices from premarket notification requirements, including tests assessing genetic health risks. ASHG responded to this request for comment by outlining its support for regulation that brings scientifically valid, evidence-based tests to market, and expressing... Read More
Media Contact: Nalini Padmanabhan ASHG Communications Manager 301.634.7346 press@ashg.org For Immediate Release Thursday, March 9, 2017 12:00 pm U.S. Eastern Time BETHESDA, MD – The American Society of Human Genetics (ASHG) applauds yesterday’s passage of S-201, the Genetic Non-Discrimination Act, in a 222-60 vote by the Parliament of Canada’s House of Commons. Because of minor... Read More